Nyxoah (NYXH) Research & Development (2021 - 2026)
Nyxoah (NYXH) recorded quarterly Research & Development of -$10307.2 in Q1 2026, down 100.0% quarter-over-quarter from $12.6 billion in Q4 2025, and down 9.01% on a YoY basis from -$11327.8 in Q1 2025.
Nyxoah (NYXH) Research & Development (2021 - 2026) Analysis & Trends
Nyxoah's Research & Development history runs 6 years deep, the most recent figure standing at -$10307.2 for Q1 2026.
- In Q1 2026, Research & Development fell 9.01% year-over-year to -$10307.2; the TTM figure through Mar 2026 stood at $12.6 billion (up 200.37% YoY), while the FY2025 annual figure was $49.8 million, up 35.9% from the prior year.
- Research & Development was -$10307.2 for Q1 2026 at Nyxoah, down from $12.6 billion in the prior quarter.
- In the past five years, Research & Development ranged from a high of $12.6 billion in Q4 2025 to a low of -$12.6 billion in Q4 2024.
- Historically, Research & Development has averaged -$1.6 billion across 5 years, with a median of -$8.0 million in 2024.
- The sharpest annual moves came in 2023 and 2025: Research & Development plunged 163689.01% in 2023, then jumped 200.71% in 2025.
- A 5-year view of Research & Development shows it stood at -$4.7 billion in 2022, then slumped by 68.76% to -$7.9 billion in 2023, then slumped by 59.43% to -$12.6 billion in 2024, then surged by 200.71% to $12.6 billion in 2025, then slumped by 100.0% to -$10307.2 in 2026.
- The last three Research & Development figures came in at -$10307.2 (Q1 2026), $12.6 billion (Q4 2025), and -$15.1 million (Q3 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | R&D (Qtr) |
|---|---|---|---|---|---|
| 1 | Intuitive Surgical | 148.09 Bn | 143.69 Bn | 1.83 Bn | 361.90 Mn |
| 2 | Becton Dickinson | 41.00 Bn | 39.99 Bn | 2.15 Bn | 249.00 Mn |
| 3 | Medline | 30.38 Bn | 36.22 Bn | 1.84 Bn | - |
| 4 | Resmed | 28.22 Bn | 26.56 Bn | 890.98 Mn | 94.27 Mn |
| 5 | West Pharmaceutical Services | 23.72 Bn | 23.19 Bn | 296.40 Mn | 15.80 Mn |
| 6 | Solventum | 13.33 Bn | 13.33 Bn | 1.10 Bn | 189.00 Mn |
| 7 | Cooper Companies | 13.12 Bn | 12.99 Bn | 735.40 Mn | 42.50 Mn |
| 8 | Align Technology | 12.86 Bn | 11.80 Bn | 736.59 Mn | 98.66 Mn |
| 9 | Baxter International | 10.51 Bn | 8.47 Bn | 891.00 Mn | 139.00 Mn |
| 10 | Nyxoah | 0.69 | 0.69 | 4.26 Mn | -10,307.24 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -10,307.24 |
| Dec 31, 2025 | 12.65 Bn |
| Sep 30, 2025 | -15.09 Mn |
| Jun 30, 2025 | -11.39 Mn |
| Mar 31, 2025 | -9,455.39 |
| Dec 31, 2024 | -12.56 Bn |
| Sep 30, 2024 | -8.68 Mn |
| Jun 30, 2024 | -8.05 Mn |
| Mar 31, 2024 | -7.82 Bn |
| Dec 31, 2023 | -7.88 Bn |
| Sep 30, 2023 | -7.15 Mn |
| Jun 30, 2023 | -7.19 Mn |
| Mar 31, 2023 | -6.61 Bn |
| Dec 31, 2022 | -4.67 Bn |
| Sep 30, 2022 | -4.26 Mn |
| Jun 30, 2022 | -3.70 Mn |
| Mar 31, 2022 | -4.03 Mn |
| Dec 31, 2021 | -3.82 Bn |
| Sep 30, 2021 | -4.15 Mn |
| Jun 30, 2021 | 2.89 Mn |